Show simple document record

dc.contributor.authorLarrivée, Samuelfr
dc.contributor.authorBalg, Frédéricfr
dc.contributor.authorLéonard, Guillaumefr
dc.contributor.authorBédard, Soniafr
dc.contributor.authorTousignant, Michelfr
dc.contributor.authorBoissy, Patrickfr
dc.date.accessioned2021-04-13T19:46:44Z
dc.date.available2021-04-13T19:46:44Z
dc.date.created2021fr
dc.date.issued2021-04-13
dc.identifierPMCID:PMC7948354fr
dc.identifier.urihttp://hdl.handle.net/11143/18295
dc.description.abstractBackground: Subacromial pain syndrome (SAPS) is a common complaint in orthopaedics. Subacromial corticosteroid injections (CSI) can relieve pain in the short term. Anodal transcranial direct current stimulation (a-tDCS) has been used for symptomatic pain relief in a variety of chronic pain conditions. The aim of this pilot study was to assess whether the application a-tDCS could enhance the symptomatic relief provided by CSI in patients affected by SAPS. Methods: Thirty-eight participants (18 to 65-year-old) suffering from SAPS were recruited to have a CSI and randomly allocated to receive, 1 weeks post CSI, real a-tDCS (r-tDCS), sham tDCS (s-tDCS) or no intervention (Control). Upper limb function was measured 1 week prior to the CSI, at the 2- and 4-week follow-ups using self-administered questionnaires and physical measures. Self-reported pain and activity during each day were logged by the participants using visual analog scales (VAS). Differences between groups were tested using repeated-measures ANOVAs. Results: Pain VAS and the Single Assessment Numeric Evaluation scale (SANE) showed significant improvement from baseline 2 weeks and 4 weeks after CSI in all groups (p < 0.05). There were no significant group X time interaction 2 weeks following tDCS treatment in any of the variables. Conclusion: All groups showed significant improvement in pain VAS and SANE scores following the CSI. One session of a-tDCS treatment 2 weeks following CSI did not result in any additive or potentializing effects when compared to a s-tDCS or a control group.fr
dc.language.isoengfr
dc.relation.isformatofhttps://doi.org/10.1186/s12891-021-04139-2fr
dc.relation.ispartofISSN:1471-2474fr
dc.relation.ispartofBMC Musculoskeletal Disordersfr
dc.rightsAttribution - Pas d’Utilisation Commerciale - Pas de Modification 2.5 Canada*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/ca/*
dc.subjectSubacromial pain syndromefr
dc.subjectSubacromial bursitisfr
dc.subjectShoulder activityfr
dc.subjectAccelerometryfr
dc.subjectRotator cuff tendinitisfr
dc.titleTranscranial direct current stimulation (a-tCDS) after subacromial injections in patients with subacromial pain syndrome: a randomized controlled pilot studyfr
dc.typeArticlefr
udes.description.typestatusPost-publicationfr
udes.description.typepubRévisé et accepté par des pairsfr
udes.description.pagesarticle e265fr
udes.description.period22fr
udes.description.sponsorshipFond de Recherche et Enseignement en Orthopédie de Sherbrooke (FREOS)fr
udes.description.diffusionDiffusé par Savoirs UdeS, le dépôt institutionnel de l'Université de Sherbrookefr
dc.identifier.bibliographicCitationLarrivée, S., Balg, F., Léonard, G., Bédard, S., Tousignant, M. et Boissy, P. (2021). Transcranial direct current stimulation (a-tCDS) after subacromial injections in patients with subacromial pain syndrome: a randomized controlled pilot study. "BMC Musculoskelet Disord", 22, article e265. https://doi.org/10.1186/s12891-021-04139-2fr
udes.description.sourceBMC Musculoskeletal Disordersfr
udes.autorisation.depottruefr
udes.description.ordreauteursLarrivée, Samuel; Balg, Frédéric; Léonard, Guillaume; Bédard, Sonia; Tousignant, Michel; Boissy, Patrickfr


Files in this document

Thumbnail
Thumbnail

This document appears in the following Collection(s)

Show simple document record

Attribution - Pas d’Utilisation Commerciale - Pas de Modification 2.5 Canada
Except where otherwise noted, this document's license is described as Attribution - Pas d’Utilisation Commerciale - Pas de Modification 2.5 Canada